Replies to post #3165 on Delcath Systems Inc (DCTH)

[ash111]

Agree. people are usually focusing US.market only but DCTH is a major P2/P3 World player for Duct Cancer and deep in EU market:
CHEMOSAT Available At Major Cancer Centers Throughout European Region:
1. CE Marked as Class IIb Medical Device with broad indication
2. >300 commercial procedures performed
3. Broad range of tumor types treated
4. Expansion into Turkey March 2016
5. National reimbursement established in Germany for 2016 after <3 years of commercial activity

2H2016:
• German ZE Reimbursement Level Defined
• P2 ICC Cohort Enrollment Completed
• EU Registry Data Readout #2

$32.2 million aggregate proceeds to fund clinical development programs, commercial activities & ongoing operations .market cap is only $4.5m a/o today w/many upcoming Catalysts.great potential imo.